Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on motsugibatorep eye drops for treatment-resistant dry eye
jRCT1071260084Recruiting
- Sponsor
- Miyata Eye Hospital
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of motsugibatorep in dry eye syndrome (DED), sponsored by Miyata Eye Hospital. Primary endpoint: Change from baseline in total J-OSDI score at 2 weeks. Started Sep 2026; status: recruiting.
02
Drugs
motsugibatorep
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT1071260084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071260084.